AFL

Aflac Incorporated (AFLAC) - Q1 2005 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report (Form 10-Q) for Aflac Incorporated and subsidiaries for the period ended March 31, 2005. Aflac primarily sells supplemental health and life insurance in the United States and Japan. The company operates two reportable segments: Aflac Japan and Aflac U.S. Financial results for the prior year have been adjusted to reflect the adoption of SFAS 123R (Share-Based Payment) effective January 1, 2005.

Key Financial Metrics

Margins: The combined effective income tax rate was 35.2% in Q1 2005 versus 34.8% in Q1 2004. Aflac Japan's pretax operating profit margin expanded to 14.9% from 13.9% year-over-year.

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 8.5% to $3.559 billion, driven by a 9.7% increase in premiums and an 8.4% increase in net investment income.
• Profitability: Net earnings rose 7.9% to $328 million. Pretax operating earnings increased to $516 million from $443 million.
• Segment Performance:
  • Aflac Japan: Pretax operating earnings grew 17.6% to $399 million. Premium income increased 9.3% (6.5% in yen terms) due to growth in premiums in force and new sales.
  • Aflac U.S.: Pretax operating earnings grew 9.7% to $133 million. Premium income increased 10.7%.
• Cash Position: Cash and cash equivalents decreased significantly to $992 million from $3.8 billion. This was primarily due to the return of $2.6 billion in cash collateral from securities lending activities at the end of 2004 and subsequent reinvestment.
• Foreign Currency: The yen weakened to 107.39 per dollar at quarter-end (from 104.21), reducing reported assets and liabilities by approximately $1.4 billion and $1.3 billion, respectively, compared to prior period exchange rates.

Guidance, Outlook, and Risks

• 2005 Guidance: Management projects net earnings per diluted share of at least $2.56 for 2005, representing a 14.8% increase over 2004. This projection assumes no impact from foreign currency translation, no realized investment gains/losses, and no nonrecurring items.
• 2006 Outlook: The objective is a 15% increase in net earnings per diluted share.
• Sales Targets: Aflac Japan aims for 5-10% growth in new annualized premium sales (yen basis). Aflac U.S. targets 3-8% growth.
• Key Risks:
  • Foreign Exchange: Fluctuations in the yen/dollar rate significantly impact reported results. A weaker yen suppresses reported earnings.
  • Interest Rates: A 100 basis point increase in rates could reduce the fair value of debt securities by approximately $4.8 billion.
  • Investment Credit Risk: The portfolio includes $778 million in below-investment-grade securities (amortized cost), though management believes declines are temporary and not credit-related.
  • Regulatory: Restrictions on fund transfers from Aflac Japan to the Parent Company based on financial strength requirements.

Investor Verification Checklist

• Foreign Currency Impact: Verify the sensitivity of earnings to yen/dollar exchange rates, as the company explicitly excludes this from guidance but it materially affects reported results.
• Investment Portfolio Quality: Review the $778 million in below-investment-grade securities and the $4.8 billion potential fair value decline from interest rate hikes.
• Cash Flow Volatility: Confirm the sustainability of operating cash flows given the significant swing in cash collateral from securities lending ($2.6 billion return in Q1).
• Accounting Changes: Ensure comparisons with pre-2005 data account for the adoption of SFAS 123R (expensing of stock options).
• Share Repurchases: Note that approximately 24 million shares remain available under the current repurchase program.